[go: up one dir, main page]

AU2003277416A1 - Clofarabine and platinum chemotherapy combination - Google Patents

Clofarabine and platinum chemotherapy combination

Info

Publication number
AU2003277416A1
AU2003277416A1 AU2003277416A AU2003277416A AU2003277416A1 AU 2003277416 A1 AU2003277416 A1 AU 2003277416A1 AU 2003277416 A AU2003277416 A AU 2003277416A AU 2003277416 A AU2003277416 A AU 2003277416A AU 2003277416 A1 AU2003277416 A1 AU 2003277416A1
Authority
AU
Australia
Prior art keywords
clofarabine
chemotherapy combination
platinum chemotherapy
platinum
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003277416A
Inventor
Katherine Stephenson
Steven D. Weitman
Sean T. Wilson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ilex Products Inc
Original Assignee
Ilex Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ilex Products Inc filed Critical Ilex Products Inc
Publication of AU2003277416A1 publication Critical patent/AU2003277416A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2003277416A 2002-10-16 2003-10-14 Clofarabine and platinum chemotherapy combination Abandoned AU2003277416A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41906402P 2002-10-16 2002-10-16
US60/419,064 2002-10-16
PCT/US2003/032889 WO2004035043A1 (en) 2002-10-16 2003-10-14 Clofarabine and platinum chemotherapy combination

Publications (1)

Publication Number Publication Date
AU2003277416A1 true AU2003277416A1 (en) 2004-05-04

Family

ID=32108020

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003277416A Abandoned AU2003277416A1 (en) 2002-10-16 2003-10-14 Clofarabine and platinum chemotherapy combination

Country Status (2)

Country Link
AU (1) AU2003277416A1 (en)
WO (1) WO2004035043A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1875936B (en) * 2006-07-18 2010-05-19 济南康泉医药科技有限公司 Anticancer sustained release agent containing clorfarabine and cytotoxic drug
JP6857365B2 (en) * 2016-03-11 2021-04-14 国立大学法人 鹿児島大学 Anti-liver tumor virus agent

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5562925A (en) * 1970-04-20 1996-10-08 Research Corporation Tech. Inc. Anti-tumor method
JPS6041077B2 (en) * 1976-09-06 1985-09-13 喜徳 喜谷 Cis platinum(2) complex of 1,2-diaminocyclohexane isomer
US5384310A (en) * 1989-05-23 1995-01-24 Southern Research Institute 2'-fluoro-2-haloarabinoadinosines and their pharmaceutical compositions

Also Published As

Publication number Publication date
WO2004035043A1 (en) 2004-04-29

Similar Documents

Publication Publication Date Title
AU2003282478A1 (en) Discount-instrument methods and systems
AU2003301680A1 (en) Platinum complexes
AU2003202943A1 (en) Flow sorting system and methods regarding same
AU2003286819A1 (en) Alternate delivery location methods and systems
EP1573463A3 (en) Alternate delivery location methods and systems
AU2002952106A0 (en) Methods and systems (npw008)
AUPS049102A0 (en) Methods and systems (ap51)
AUPS020302A0 (en) Methods and systems (npw007)
AU2003263747A1 (en) Test system and methodology
AU2003220350A1 (en) Full bore selective location and orientation system
AUPS048902A0 (en) Methods and systems (ap49)
AU2002364051A1 (en) Anti-cancer combination and use thereof
AUPS048802A0 (en) Methods and systems (ap48)
AUPS048602A0 (en) Methods and systems (ap46)
AUPS048402A0 (en) Methods and systems (ap43)
AU2003210541A1 (en) Health improvement systems and methods
AUPS047402A0 (en) Methods and systems (ap65)
AUPS047502A0 (en) Methods and systems (ap66)
AU2003231827A1 (en) Pseudo-tissues and uses thereof
AUPS048302A0 (en) Methods and systems (ap79)
AU2003277416A1 (en) Clofarabine and platinum chemotherapy combination
AU2003302173A1 (en) Spirotetrathiocarbamates and spirooxothiocarbamates
AUPS048202A0 (en) Methods and systems (ap78)
AUPS047702A0 (en) Methods and systems (ap68)
AUPS047602A0 (en) Methods and systems (ap67)

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase